Cardiovascular Disease
Top in cardiology: Heart complications in COVID-19; safety of hormone therapy
A recent study found that men were more likely than women to have cardiovascular complications during hospitalization with COVID-19.
Higher intake of added sugars associated with higher CVD risk
Higher intake of free sugars was linked to a higher risk for CVD, and substituting them with non-free sugars was inversely associated with both total CVD and stroke incidence, a recent study showed.
The potential next pathway to target in CVD prevention: ‘Common’ elevated Lp(a)
About 20% of the global population and one in five U.S. adults have elevated levels of lipoprotein(a), a complex form of LDL that strongly predicts risk for coronary disease and aortic valve stenosis.
Escaping the Current Gaps in the Understanding and Treatment of CKD Anemia: Making Sense of Emerging Therapies
Supported by an educational grant from GSK
Clinicians provide recommendations for sick day medication guidance
A group of clinicians provided 46 consensus recommendations for sick day medication guidance for patients with diabetes, kidney or cardiovascular disease, according to data published in the American Journal of Kidney Diseases.
Care must continue ‘well after date of surgery’ in patients with chronic pancreatitis
Infection, cardiovascular disease, narcotic dependence and other psychosocial issues were among causes linked to reduced 10-year survival in patients who underwent surgical intervention for chronic pancreatitis, researchers reported.
Preeclampsia raises risks for future myocardial infarction, ischemic stroke
The odds of myocardial infarction and ischemic stroke are greater among women with vs. without preeclampsia for more than 20 years after pregnancy, according to findings published in the European Journal of Preventive Cardiology.
The Disproportionate Burden of Heart Failure in Women: Advances & Expert Perspectives to Improve Diagnosis & Treatment
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Assessing the Evolving Role of GLP1-RAs to Reduce Cardiovascular Risk: Emerging Evidence, Evolving Guidance, and Expert Perspectives
Supported by an educational grant from Novo Nordisk
Mortality twice as high for patients with IBD, non-STEMI vs. IBD alone
DENVER — Patients with inflammatory bowel disease and non-ST elevation myocardial infarction had higher mortality, hospital stays and hospital charges than patients with IBD alone, noted a presenter at the Crohn’s and Colitis Congress.